Quick Answer
Cardlytics, Inc. reported Stockholders Equity of -$6.51 million for the year ending 2025.
- Cardlytics, Inc. showed a decrease of -109.3% in Stockholders Equity from 2024 to 2025.
- This data is from Cardlytics, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: -$203.57 million | Q3 2017: -$205.25 million | Q1 2018: $40.56 million | Q2 2018: $36.77 million | Q3 2018: $51.23 million | Q1 2019: $47.18 million | Q2 2019: $46.54 million | Q3 2019: $127.32 million | Q1 2020: $138.36 million | Q2 2020: $130.47 million | Q3 2020: $150.36 million | Q1 2021: $744.89 million | Q2 2021: $714.39 million | Q3 2021: $688.62 million | Q1 2022: $711.67 million | Q2 2022: $564.16 million | Q3 2022: $580.51 million | Q1 2023: $232.32 million | Q2 2023: $236.11 million | Q3 2023: $225.34 million | Q1 2024: $199.14 million | Q2 2024: $210.03 million | Q3 2024: $69.70 million | Q1 2025: $64.09 million | Q2 2025: $58.71 million | Q3 2025: -$4.70 million.
- Over the full 11 years of available data (2015 to 2025), Cardlytics, Inc.'s Stockholders Equity has grown by 96.0%.
- Historical annual values: Fiscal year 2025: -$6.51 million | Fiscal year 2024: $69.99 million | Fiscal year 2023: $134.80 million | Fiscal year 2022: $211.61 million | Fiscal year 2021: $690.70 million | Fiscal year 2020: $157.19 million | Fiscal year 2019: $143.27 million | Fiscal year 2018: $51.98 million | Fiscal year 2017: -$208.69 million | Fiscal year 2016: -$216.84 million | Fiscal year 2015: -$162.16 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: